262 related articles for article (PubMed ID: 3913034)
1. Intermediate dose methotrexate (IDM) in children with acute lymphocytic leukemia (ALL). An update.
Freeman AI
Sangre (Barc); 1985; 30(6):1007-33. PubMed ID: 3913034
[No Abstract] [Full Text] [Related]
2. [Treatment of acute childhood leukemia. A new protocol 811 for the standard risk group of acute lymphocytic leukemia (Phase III study)].
Koizumi S; Fujimoto T; Higashi O; Utsumi J; Mimaya J; Sekine I; Shike S; Imashuku S; Yamamoto S; Ninomiya T
Rinsho Ketsueki; 1983 Dec; 24(12):1633-40. PubMed ID: 6368900
[No Abstract] [Full Text] [Related]
3. [Acute lymphoblastic leukemia of high risk: results of a therapeutic protocol].
Castel V; Verdeguer A; Ferris J; Esquembre C
An Esp Pediatr; 1987 Nov; 27(5):331-4. PubMed ID: 3481522
[TBL] [Abstract][Full Text] [Related]
4. [Consolidating chemotherapy in the treatment program of acute lymphoblastic leukemia in children].
Maiakova SA; Makhonova LA
Vestn Akad Med Nauk SSSR; 1986; (5):15-7. PubMed ID: 3487897
[No Abstract] [Full Text] [Related]
5. Intermediate dose methotrexate and sequential L-asparaginase for treatment of refractory acute lymphocytic leukaemia.
Shetty PA; Kurkure PA; Dasgupta A
Indian J Cancer; 1984; 21(1):45-9. PubMed ID: 6595214
[No Abstract] [Full Text] [Related]
6. Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia.
Sallan SE; Hitchcock-Bryan S; Gelber R; Cassady JR; Frei E; Nathan DG
Cancer Res; 1983 Nov; 43(11):5601-7. PubMed ID: 6352020
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of acute childhood leukemia. A new protocol 811 for the high risk group of acute lymphocytic leukemia (Phase III study)].
Mimaya J; Fujimoto T; Hiyoshi Y; Yanai M; Komazawa M; Sekine I; Koizumi S; Nishikawa K; Higashi O; Utsumi J
Rinsho Ketsueki; 1984 Aug; 25(8):1190-6. PubMed ID: 6392601
[No Abstract] [Full Text] [Related]
8. [Treatment of acute lymphoblastic leukemia in children: modified LSA2-L2 therapy].
Ishii E; Hara T; Ueda K; Kishida K; Nakamura E; Miyazaki S; Yoshida N
Rinsho Ketsueki; 1985 Apr; 26(4):487-93. PubMed ID: 3862888
[No Abstract] [Full Text] [Related]
9. [Study on the treatment of acute lymphoblastic leukemia with T-cell markers in children].
Nishikawa A; Saito K; Taniuchi S; Ohnishi T; Matsumura T
Rinsho Ketsueki; 1984 May; 25(5):660-5. PubMed ID: 6332214
[No Abstract] [Full Text] [Related]
10. [Results of 2 chemotherapy protocols (VPA and C-VPA) in acute adult lymphoblastic leukemia].
Avilés Miranda A; Ambriz Fernández R; Díaz Maqueo JC; Mascaró Sacristán J; Sinco Angeles A; Pizzuto J
Rev Invest Clin; 1983; 35(4):285-9. PubMed ID: 6369467
[No Abstract] [Full Text] [Related]
11. [Do non-localized non-Hodgkin's lymphoma and acute lymphoblastic leukemia with large tumor masses require the same therapy?].
Pastore G; Cordero di Montezemolo L; Boschis MP; Ghibaudo P; Saracco P; Miniero R; Madon E; Forni M; Saitta M
Haematologica; 1985; 70(4):313-8. PubMed ID: 3935529
[No Abstract] [Full Text] [Related]
12. [Results of the treatment of lymphoblastic leukemia by the BFM program in children--a 5-year observation].
Rokicka-Milewska R; Derulska D; Makowska K; Skwarska E; Lewicki Z
Acta Haematol Pol; 1987; 18(1-2):1-8. PubMed ID: 3481150
[No Abstract] [Full Text] [Related]
13. [L-Asparaginase in the treatment of acute leukemia].
Mathé G; Amiel JL; Clarysse A; Hayat M; Schwarzenberg L; Schneider M
Sem Hop; 1970 Apr; 46(17):1135-40. PubMed ID: 4315231
[No Abstract] [Full Text] [Related]
14. [Intensive chemotherapy of acute lymphoblastic leukemia in childhood: evaluation of our experience].
Tontoli N; Correra A; Saviano P; Vetrella A; De Masi RV; Florino G; Lagonigro F
Pediatria (Napoli); 1981 Dec; 89(4):805-13. PubMed ID: 6955759
[No Abstract] [Full Text] [Related]
15. Evaluation of a polychemotherapeutic regimen including Idarubicin (4-demethoxydaunorubicin) in relapsed acute lymphocytic leukemia.
Mandelli F; Testi AM; Aloe Spiriti MA; Giona F; Meloni G; Moleti ML; Amadori S; Pacciarini MA
Haematologica; 1986; 71(1):34-8. PubMed ID: 3084353
[No Abstract] [Full Text] [Related]
16. [Comparison of the results of treatment of lymphoblastic leukemia in children by different methods].
Derulska D; Rokicka-Milewska R; Skrobowska-Woźniak A; Makowska K; Kansy J
Pediatr Pol; 1981 Sep; 56(9):985-92. PubMed ID: 6948273
[No Abstract] [Full Text] [Related]
17. Hemostatic changes in children with acute lymphoblastic leukemia treated according to two different L-asparaginase schedules.
Miniero R; Pastore G; Saracco P; Messina M; Lange MM; Fiandino G; Iannacci L; Madon E
Am J Pediatr Hematol Oncol; 1986; 8(2):116-20. PubMed ID: 3461716
[TBL] [Abstract][Full Text] [Related]
18. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.
Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E
Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428
[TBL] [Abstract][Full Text] [Related]
19. [Results of 2 protocols in the treatment of acute lymphoid leukemia in children, according to prognostic factors].
Misset JL; Gil-Delgado MA; Delgado M; de Vassal F; Machover D; Goutner A; Mathé G
Rev Esp Oncol; 1982; 29(4):785-801. PubMed ID: 6965045
[TBL] [Abstract][Full Text] [Related]
20. Preliminary result of a new protocol for the active immunotherapy of acute lymphoblastic leukaemia: inhibition of the immunotherapeutic effect by Vincristine or Adamantadine.
Mathé G; Amiel JL; Schwarzenberg L; Schneider M; Hayat M; de Vassal F; Jasmin C; Rosenfeld C; Pouillart P
Rev Eur Etud Clin Biol; 1971 Mar; 16(3):216-24. PubMed ID: 4997294
[No Abstract] [Full Text] [Related]
[Next] [New Search]
